In addition, expression inhibition of TMPO, TOP2A, RFC3, GINS1, and CKS2 genes could prevent tumor growth and TRIB3 expression suppression would be a favorable target for anti−angiogenic therapy. The gene discussed is RFC3; the disease is neoplasm.